Latest: FDA Approves New Biosimilar for Oncology Treatment

Opinion: End the unchecked growth of publishing fees and the overreliance on unpaid peer review

0 Mins
High publishing costs and a crumbling peer review infrastructure are symptoms of deeper structural issues in research.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago